Rosemary Osborne, PhD
Dr. Rosemarie Osborne is a Principal Scientist at P&G Beauty and has been working to develop in vitro model systems to further promote the study of skin and hair. Dr. Osborne is credited for developing in vitro skin and eye test methods that have been accepted by international regulatory agencies and are currently industry standards for the evaluation of consumer products and ingredients. Dr. Osborne’s collaborations with Dr. May Griffith at the University of Ottawa have led to the development of artificial corneas which are undergoing human transplant clinical trials. Her current research is in the field of skin aging.
Dr. Osborne has held a number of appointments with prestigious organizations, including membership with the Industrial In Vitro Toxicology Group and positions on The International Foundation for Ethical Research, the Institute for In Vitro Sciences and the Development Committee for the Society for in vitro Biology. She is an accomplished research scientist and has co-authored numerous original articles, book chapters, reviews and abstracts on a variety of topics including use of in vitro models in skin aging research, corneal equivalents constructed from cell lines and alternative methods, which have been published in journals such as Science and Food and Chemical Toxicology and Science, in addition to the book Dermatotoxicology Methods. She has presented her scientific findings on in vitro methods, animal alternatives, and skin aging at the Society of Toxicology, American Academy of Dermatology, Society for Investigative Dermatology, World Congress of Dermatology and as a participant on the European Center for Alternatives to Animal Methods Expert Panel.
Dr. Osborne completed her undergraduate studies at Skidmore College and received her Ph.D. in Pharmacology from Harvard University. After obtaining her Ph.D., she was an NIH postdoctoral fellow at the CIIT Centers for Health Research in the Department of Cellular & Molecular Toxicology. Dr. Osborne has been with P&G for more than 19 years.